文化适配生活方式干预对南亚裔心血管风险因素的影响:SAHELI随机临床试验
该单盲随机临床试验在美国芝加哥地区纳入549名18至65岁超重或肥胖、无心血管事件史且至少有一项额外心血管风险因素的南亚裔成人,比较为期16周的文化适配团体生活方式干预与书面健康教育材料对12个月时心血管风险因素变化的影响。结果显示,干预组与对照组在体重、收缩压、舒张压、总胆固醇和糖化血红蛋白变化上均无显著组间差异,但干预参与与饮食质量、体力活动和自我效能的小幅改善相关。
要点
- 文化适配团体生活方式干预未比书面健康教育更有效降低南亚裔成人的心血管风险因素。
- 干预参与与饮食质量、体力活动和自我效能的小幅改善相关。
- 针对该高风险人群的有效心血管预防干预仍需进一步研究。
核心结论
- 在美国南亚裔成人中,文化适配的团体生活方式干预在降低心血管风险因素方面并不优于书面健康教育材料,但干预与自我报告健康行为的小幅改善相关。
研究设计与样本
- 单盲随机临床试验,2018年3月6日至2023年2月11日在芝加哥都会区社区场所开展,共随机549名18至65岁南亚裔成人。
- 纳入标准为超重或肥胖、无心血管事件史且至少有一项额外心血管风险因素(高血压、血脂异常、糖尿病前期或糖尿病)。
- 干预为16周文化适配团体生活方式干预,由社区健康教练以英语、古吉拉特语、印地语和乌尔都语提供咨询,参与者追踪饮食和体力活动,并在随访第5至11个月接受4次可选团体维持课程;对照组每月接收书面健康教育材料。
主要发现
- 干预组与对照组从基线至12个月的心血管风险因素变化均无显著组间差异:体重均差-0.07 kg(95%CI -0.55至0.42),收缩压均差0.47 mm Hg(95%CI -1.85至2.79),舒张压均差0.44 mm Hg(95%CI -1.06至1.95),总胆固醇均差-2.47 mg/dL(95%CI -8.51至3.57),糖化血红蛋白均差-0.07%(95%CI -0.20%至0.07%)。
- 干预参与与饮食质量、体力活动和自我效能较对照组有更大改善相关。
临床怎么用
- 对于美国南亚裔心血管风险人群,文化适配团体生活方式干预在改善体重、血压、血脂和血糖方面未显示优于书面健康教育,不应预期其能显著改善这些临床风险因素。
- 该干预可能有助于改善饮食质量、体力活动和自我效能等健康行为,可作为行为支持的辅助手段。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: South Asian adults in the US experience excess cardiovascular disease (CVD) compared with other racial and ethnic groups. The effectiveness and reach of guideline-recommended lifestyle interventions have not been evaluated in this population. OBJECTIVE: To evaluate whether a culturally adapted, group lifestyle intervention will improve CVD risk factors more effectively than written health education materials among US South Asian adults. DESIGN, SETTING, AND PARTICIPANTS: This single-blind randomized clinical trial was conducted from March 6, 2018, to February 11, 2023 at community sites in the Chicago, Illinois, metropolitan area. South Asian adults aged 18 to 65 years who were overweight or obese, had no history of CVD events, and had at least 1 additional CVD risk factor (hypertension, dyslipidemia, prediabetes, or diabetes) were eligible for inclusion. INTERVENTION: A 16-week, culturally adapted, group-based lifestyle intervention led by community health coaches. Lifestyle modification counseling was delivered in English, Gujarati, Hindi, and Urdu. Participants tracked their diet and physical activity (PA) and received 4 optional group maintenance sessions between months 5 and 11 of follow-up. The intervention was delivered in person prior to the onset of the COVID-19 pandemic and via videoconference starting in March 2020. The control group received written health education materials, delivered monthly. MAIN OUTCOMES AND MEASURES: Primary outcomes were the between-group differences in CVD risk factor changes from baseline to 12 months, including weight, systolic blood pressure (SBP), diastolic blood pressure (DBP), glycated hemoglobin (HbA1c), and total cholesterol, estimated using multivariate mixed-effects regression models. Secondary outcomes were self-reported diet quality, PA, and self-efficacy, estimated using univariate mixed-effects regression models. RESULTS: Among 549 randomized participants, 318 (57.9%) were women, and mean (SD) participant age was 49.2 (9.5) years. Mean differences in CVD risk factor changes from baseline to 12 months in the intervention vs control group were calculated for weight (mean difference, -0.07 kg; 95% CI, -0.55 to 0.42), SBP (mean difference, 0.47 mm Hg; 95% CI, -1.85 to 2.79), DBP (mean difference, 0.44 mm Hg; 95% CI, -1.06 to 1.95), cholesterol (mean difference, -2.47 mg/dL; 95% CI, -8.51 to 3.57), and HbA1c (mean difference, -0.07%; 95% CI -0.20% to 0.07%). Intervention participation was associated with greater improvements in dietary quality, PA, and self-efficacy than control. CONCLUSIONS AND RELEVANCE: In the SAHELI randomized clinical trial, a culturally adapted, group lifestyle intervention was not more effective than written health education materials for CVD risk factor reduction among US South Asian adults, but the intervention was associated with small improvements in self-reported health behaviors. Effective CVD prevention interventions for this elevated-risk population require further investigation. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03336255.
引用
- Kandula NR, Shah NS, Kumar S, et al. Culturally Adapted Lifestyle Intervention for South Asian Adults With Cardiovascular Risk Factors: The SAHELI Randomized Clinical Trial. JAMA Cardiol. 2024. PMID: 39259546. doi:10.1001/jamacardio.2024.2526
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。